GlassScriptPhysician profile
Ayala Lannon
NPI 1700132339
$2,280.18
in general payments reported to CMS, 2019-2025
17 companies · $727 in 2025
The $727 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $18.97 · 2021: $143 · 2022: $377 · 2023: $383 · 2024: $257 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,118 · Honoraria: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,117.70 |
| Honoraria | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $804.57 | 2019-2025 | Voyager Dslt, Hydrus Microstent, Precision 7 |
| Johnson & Johnson Vision Care, INC. | $427.39 | 2019-2025 | Acuvue |
| Visioneering Technologies, INC. | $375.74 | 2022-2025 | |
| Tarsus Pharmaceuticals, INC. | $137.74 | 2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $119.01 | 2019 | |
| Apellis Pharmaceuticals, INC. | $83.51 | 2023 | Syfovre |
| Glaukos Corporation | $71.62 | 2022 | |
| Oyster Point Pharma, INC. | $58.78 | 2022-2023 | Tyrvaya |
| Bausch & Lomb Americas INC. | $41.02 | 2023-2025 | Infuse |
| Abbvie INC. | $34.40 | 2023-2024 | |
| Dompe US, INC. | $26.19 | 2025 | Oxervate |
| Derma Sciences, INC. | $21.82 | 2019 | |
| Mallinckrodt Hospital Products INC. | $21.75 | 2024 | Acthar |
| Coopervision INC. | $15.37 | 2022 | |
| Harrow Eye, LLC | $14.89 | 2024 | Vevye |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $13.49 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.89 | 2023 | Acuvue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayala Lannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.